Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Predicting proliferative vitreoretinopathy: temporal and external validation of models based on genetic and clinical variables.

Rojas J, Fernandez I, Pastor JC, MacLaren RE, Ramkissoon Y, Harsum S, Charteris DG, Van Meurs JC, Amarakoon S, Garcia-Arumi J, Ruiz-Moreno JM, Rocha-Sousa A, Brion M, Carracedo A; Genetics on PVR Study Group (web file).

Br J Ophthalmol. 2015 Jan;99(1):41-8. doi: 10.1136/bjophthalmol-2014-305263. Epub 2014 Jul 29.

PMID:
25075124
2.

Development of predictive models of proliferative vitreoretinopathy based on genetic variables: the Retina 4 project.

Rojas J, Fernandez I, Pastor JC, Garcia-Gutierrez MT, Sanabria RM, Brion M, Sobrino B, Manzanas L, Giraldo A, Rodriguez-de la Rua E, Carracedo A.

Invest Ophthalmol Vis Sci. 2009 May;50(5):2384-90. doi: 10.1167/iovs.08-2670. Epub 2008 Dec 20.

PMID:
19098314
3.

BAX and BCL-2 polymorphisms, as predictors of proliferative vitreoretinopathy development in patients suffering retinal detachment: the Retina 4 project.

Pastor-Idoate S, Rodríguez-Hernández I, Rojas J, Fernández I, García-Gutierrez MT, Ruiz-Moreno JM, Rocha-Sousa A, Ramkissoon YD, Harsum S, MacLaren RE, Charteris DG, Van Meurs JC, González-Sarmiento R, Pastor JC; Genetics on PVR Study Group.

Acta Ophthalmol. 2015 Nov;93(7):e541-9. doi: 10.1111/aos.12718. Epub 2015 May 19.

4.

Prediction of proliferative vitreoretinopathy after retinal detachment surgery: potential of biomarker profiling.

Ricker LJ, Kessels AG, de Jager W, Hendrikse F, Kijlstra A, la Heij EC.

Am J Ophthalmol. 2012 Aug;154(2):347-354.e2. doi: 10.1016/j.ajo.2012.02.004. Epub 2012 Apr 27.

PMID:
22541653
5.

External validation of existing formulas to predict the risk of developing proliferative vitreoretinopathy: the Retina 1 Project; report 5.

Sala-Puigdollers A, Fernández I, Coco RM, Sanabria MR, Rodríguez de la Rúa E, Ruiz-Moreno JM, Navea A, Suárez de Figueroa M, Pastor JC.

Retina. 2013 Sep;33(8):1519-27. doi: 10.1097/IAE.0b013e31828991ea.

PMID:
23594721
6.

Cytokine gene polymorphisms in retinal detachment patients with and without proliferative vitreoretinopathy: a preliminary study.

Sanabria Ruiz-Colmenares MR, Pastor Jimeno JC, Garrote Adrados JA, Telleria Orriols JJ, Yugueros Fernández MI.

Acta Ophthalmol Scand. 2006 Jun;84(3):309-13.

7.

How to predict proliferative vitreoretinopathy: a prospective study.

Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Luthert PJ, Khaw PT, Aylward GW.

Ophthalmology. 2001 Jul;108(7):1184-6.

PMID:
11425672
8.

The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: the Retina 4 Project.

Pastor-Idoate S, Rodriguez-Hernández I, Rojas J, Fernández I, García-Gutierrez MT, Ruiz-Moreno JM, Rocha-Sousa A, Ramkissoon Y, Harsum S, MacLaren RE, Charteris D, van Meurs J, González-Sarmiento R, Pastor JC; Genetics on PVR Study Group*.

Ophthalmology. 2013 Mar;120(3):623-628. doi: 10.1016/j.ophtha.2012.08.019. Epub 2012 Dec 1.

PMID:
23207172
9.

Interaction between surgical procedure for repairing retinal detachment and clinical risk factors for proliferative vitreoretinopathy.

Rodriguez de la Rúa E, Pastor JC, Aragón J, Mayo-Iscar A, Martínez V, García-Arumí J, Giraldo A, Sanabria-Ruiz Colmenares MR, Miranda I.

Curr Eye Res. 2005 Feb;30(2):147-53.

PMID:
15814473
10.

Preoperative aqueous humour flare values do not predict proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment.

Mulder VC, Tode J, van Dijk EH, Purtskhvanidze K, Roider J, van Meurs JC, Treumer F.

Br J Ophthalmol. 2017 Sep;101(9):1285-1289. doi: 10.1136/bjophthalmol-2016-309134. Epub 2017 Jan 11.

PMID:
28077370
11.

Profibrotic cytokines in aqueous humour correlate with aqueous flare in patients with rhegmatogenous retinal detachment.

Hoerster R, Hermann MM, Rosentreter A, Muether PS, Kirchhof B, Fauser S.

Br J Ophthalmol. 2013 Apr;97(4):450-3. doi: 10.1136/bjophthalmol-2012-302636. Epub 2013 Jan 26.

PMID:
23355528
12.

A genetic case-control study confirms the implication of SMAD7 and TNF locus in the development of proliferative vitreoretinopathy.

Rojas J, Fernandez I, Pastor JC, Maclaren RE, Ramkissoon Y, Harsum S, Charteris DG, Van Meurs JC, Amarakoon S, Ruiz-Moreno JM, Rocha-Sousa A, Brion M, Carracedo A; Genetics on PVR Study Group.

Invest Ophthalmol Vis Sci. 2013 Mar 5;54(3):1665-78. doi: 10.1167/iovs.12-10931.

PMID:
23258148
13.

Interleukin-6 and matrix metalloproteinase expression in the subretinal fluid during proliferative vitreoretinopathy: correlation with extent, duration of RRD and PVR grade.

Symeonidis C, Papakonstantinou E, Androudi S, Tsaousis KT, Tsinopoulos I, Brazitikos P, Karakiulakis G, Diza E, Dimitrakos SA.

Cytokine. 2012 Jul;59(1):184-90. doi: 10.1016/j.cyto.2012.04.019. Epub 2012 May 10.

PMID:
22579111
14.

Anterior chamber aqueous flare is a strong predictor for proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment.

Schröder S, Muether PS, Caramoy A, Hahn M, Abdel-Salam M, Diestelhorst M, Kirchhof B, Fauser S.

Retina. 2012 Jan;32(1):38-42. doi: 10.1097/IAE.0b013e3182173753.

PMID:
21765375
15.

Retinal detachment repair by vitrectomy: simplified formulae to estimate the risk of failure.

Wickham L, Bunce C, Wong D, Charteris DG.

Br J Ophthalmol. 2011 Sep;95(9):1239-44. doi: 10.1136/bjo.2010.190314. Epub 2011 Feb 16.

PMID:
21325394
16.
17.

Characteristics of rhegmatogenous retinal detachment and their relationship to success rates of surgery.

Williamson TH, Lee EJ, Shunmugam M.

Retina. 2014 Jul;34(7):1421-7. doi: 10.1097/IAE.0000000000000094.

PMID:
24480842
18.

ASSOCIATION STUDY BETWEEN POLYMORPHISMS OF THE p53 AND LYMPHOTOXIN ALPHA (LTA) GENES AND THE RISK OF PROLIFERATIVE VITREORETINOPATHY/RETINAL DETACHMENT IN A MEXICAN POPULATION.

Quiroz-Casian N, Lozano-Giral D, Miranda-Duarte A, Garcia-Montalvo I, Rodriguez-Loaiza JL, Zenteno JC.

Retina. 2018 Jan;38(1):187-191. doi: 10.1097/IAE.0000000000001508.

PMID:
28106707
19.

Effects of lysyl oxidase genetic variants on the susceptibility to rhegmatogenous retinal detachment and proliferative vitreoretinopathy.

Yu H, Li T, Zou X, Yuan L, Hu J, Xu Z, Peng L, Zhang C, Zou Y.

Inflammation. 2013 Aug;36(4):839-44. doi: 10.1007/s10753-013-9610-6.

PMID:
23413043
20.

[Has the incidence of postoperative PVR in rhegmatogenous retinal detachment decreased?].

Bonnet M, Guenoun S, Yaniali A, Fleury J, Hajjar C, Dumas C, Duquesne N, Semiglia R.

J Fr Ophtalmol. 1996;19(11):696-704. French.

PMID:
9033891

Supplemental Content

Support Center